7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Tscan Therapeutics Inc
(NASDAQ:TCRX) 

TCRX stock logo

TScan Therapeutics is a biopharmaceutical company focused on the development of immunotherapy treatments for cancer.

Founded: 2018
CEO: David Southwell  
Sector:
Industry:

Share this website to your friends
Tscan Therapeutics Days Payable Outstanding ttm (DPO)
202107 202108 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 029.9559.8989.84119.78149.73179.68209.62
Tscan Therapeutics Days Receivable Outstanding ttm (DSO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0125.03250.05375.08500.1625.13750.15875.18
Tscan Therapeutics Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -4.09-3.5-2.92-2.33-1.75-1.17-0.580
Tscan Therapeutics Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -4.4-3.77-3.14-2.51-1.88-1.26-0.630
Tscan Therapeutics Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.811.632.443.264.074.895.7
Tscan Therapeutics P/S ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 03.246.479.7112.9516.1819.4222.66
Tscan Therapeutics (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -7.66-6.56-5.47-4.38-3.28-2.19-1.090
Tscan Therapeutics P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.641.271.912.553.183.824.46
No extra charts and metrics for this ticker.